TAT Technologies Announces Proposed Private Placement to Israeli Institutional and Accredited Investors

In This Article:

NETANYA, Israel, Sept. 1, 2024 /PRNewswire/ -- TAT Technologies Ltd. (NASDAQ and TASE: TATT - News) ("TAT" or the "Company"), a leading provider of products and services to the commercial and military aerospace and ground defense industries, announced today that, following the approval of its Board of Directors, it has received and accepted commitments from Israeli institutional and accredited investors (as defined under Israel's Securities Law, 5728-1968) (the "Investors"), to participate in a private placement (the "Private Placement") of Ordinary Shares of the Company ("Ordinary Shares").

The Company is expected to issue and sell to the Investors an aggregate of 673,340 Ordinary Shares (the "Shares"), for a purchase price of NIS 54.95 per Share (approximately $15.03 per Share*). The newly issued Shares are expected to represent approximately 6.2% of the Company's issued and outstanding Ordinary Shares after the consummation of such sale. The closing of the transaction is subject to customary closing conditions and is expected to be completed in September 2024.

The Company expects to receive net proceeds from the sale of the Shares, after deducting offering expenses, of approximately NIS 36.5 million (or approximately $10.0 million*). The Company intends to use such proceeds for general corporate purposes.

In addition, FIMI Israel Opportunity FIVE, Limited Partnership and FIMI Opportunity V, L.P. (the "FIMI Funds"), the Company's largest shareholder, notified the Company that it received and accepted commitments from Israeli institutional and accredited investors to purchase from the FIMI Funds an aggregate of 2,349,706 Ordinary Shares, for a purchase price of NIS 54.95 per Ordinary Share (approximately $15.03 per Ordinary Share*), or an aggregate of NIS 129.1 million (approximately $35.3 million*). The Company will not receive any proceeds from the sale of the Ordinary Shares by the FIMI Funds. Following the consummation of the Private Placement and the private sale of Ordinary Shares by the FIMI Funds, the FIMI Funds are expected to beneficially own approximately 26.8% of the Company's issued and outstanding Ordinary Shares.

The Private Placement and the sale by the FIMI Funds are being made in Israel only and not to U.S. persons, as defined in Rule 902 of the U.S. Securities Act of 1933, as amended (the "Securities Act"), pursuant to a registration exemption afforded by Regulation S promulgated under the Securities Act, and the Shares will be subject to certain transfer restrictions. The Shares will not be registered under the Securities Act and will not be offered or sold in the United States without registration or applicable exemption from the registration requirements according to the Securities Act.